Skip to content

Clinical trail of ShenGuo LaoNian cold granule

Clinical trail of ShenGuo LaoNian cold granule

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-14005662
Enrollment
Unknown
Registered
2014-12-11
Start date
2014-12-15
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

common cold

Interventions

High dose group :3 bag of ShenGuo LaoNian cold granule / time, 3 times / day
Middle dose group:2 bag of ShenGuo LaoNian cold granule +1 grain of placebo particles / time, 3 times / day
Low dose group:1 bag of ShenGuo LaoNian cold granule +2 grain of placebo particles / time, 3 times / day
control group:3 grain of placebo particles / time, 3 times / day

Sponsors

West China Hospital, West China School of Medicine, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 74 Years

Inclusion criteria

Inclusion criteria: (1) consistent with western medicine diagnosis standard of common cold; (2) consistent with diagnostic criteria of cold syndrome of qi deficiency; (3) always aversion to cold, and qi deficiency of spleen and lung, can easily catching cold when season or clinate change than ordinary people (more than 6 per year); or easily fatigue, loss of appetite, etc.; (4) elderly patients between the ages of 45-74; (5) within 48 hours of onset; (6) subjects were informed and signed the informed consent.

Exclusion criteria

Exclusion criteria: (1) with acute viral or herpes pharyngitis and laryngitis, acute conjunctivitis pharynx, acute tonsillitis and other diseases; (2) with cardiovascular, pulmonary, renal and hematopoietic system, severe primary disease and diabetes or previous abnormal glucose tolerance test; ECG abnormal with clinical significance; (3) liver function test values (ALT, AST) more than 1.5 times the upper limit of normal value of serum creatinine; abnormal; abnormal glucose and postprandial 2 hour blood glucose; positive reaction on urine protein; white blood cell less than 3*10^9/L or more than 10*10^9/L; and / or neutrophil percentage more than 5% of normal value; (4) Had used other drugs in the treatment of this disease after the onset of the disease; (5) temperature higher than 38.5 degree; (6) prepare for pregnancy or pregnant women, breast-feeding women; (7) allergic to the drug or components of the drug; (8) disabled on the spirit or legally; (9) enrolled in other drug clinical trials in the past 3 months.

Design outcomes

Primary

MeasureTime frame
The time of common cold symptoms disappear;The time of common cold single symptoms disappear;The single main syndrome symptoms disappearance rate on the third day, fifth day;The curative effect of TCM main symptoms;Effect of TCM Syndromes;

Countries

China

Contacts

Public ContactMao Bing

West China Hospital, West China School of Medicine, Sichuan University

maobing@medmail.com.cn+86 18980601724

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026